Search

Your search keyword '"Simpson, Iain"' showing total 203 results
Start Over Author "Simpson, Iain" Database Unpaywall
203 results on '"Simpson, Iain"'

2. Cardiovascular symptoms

Author

Japp, Alan G., primary, Simpson, Iain, additional, Pettit, Stephen, additional, Yue, Arthur, additional, and Zaman, Junaid, additional

Published
2018
Full Text
View/download PDF

3. Supplementary Figure 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 3 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure 4 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure 3 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure 5 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure 2 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 2 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

13. Data from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 4 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 5 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

16. Data from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 4 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 4 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

19. Data from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 5 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 2 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 3 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 3 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 5 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 2 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, primary, Hernandez, Marylens, primary, Srinivasan, Srimathi, primary, Tentarelli, Sharon, primary, Griffin, Matthew, primary, Wang, Yanjun, primary, Pop-Damkov, Petar, primary, Prickett, Laura B., primary, Kankkonen, Cecilia, primary, Shen, Minhui, primary, Martin, Maryann San, primary, Wu, Song, primary, Castaldi, M. Paola, primary, Ghadially, Hormas, primary, Varnes, Jeffrey, primary, Gales, Sonya, primary, Henry, David, primary, Hoover, Clare, primary, Mele, Deanna A., primary, Simpson, Iain, primary, Gangl, Eric T., primary, Mlynarski, Scott N., primary, Finlay, M. Raymond V., primary, Drew, Lisa, primary, Fawell, Stephen E., primary, Shao, Wenlin, primary, and Schuller, Alwin G., primary

Published
2023
Full Text
View/download PDF

30. Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

Author

Doshi, Aatman S., primary, Cantin, Susan, additional, Hernandez, Marylens, additional, Srinivasan, Srimathi, additional, Tentarelli, Sharon, additional, Griffin, Matthew, additional, Wang, Yanjun, additional, Pop-Damkov, Petar, additional, Prickett, Laura B., additional, Kankkonen, Cecilia, additional, Shen, Minhui, additional, Martin, Maryann San, additional, Wu, Song, additional, Castaldi, M. Paola, additional, Ghadially, Hormas, additional, Varnes, Jeffrey, additional, Gales, Sonya, additional, Henry, David, additional, Hoover, Clare, additional, Mele, Deanna A., additional, Simpson, Iain, additional, Gangl, Eric T., additional, Mlynarski, Scott N., additional, Finlay, M. Raymond V., additional, Drew, Lisa, additional, Fawell, Stephen E., additional, Shao, Wenlin, additional, and Schuller, Alwin G., additional

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 2 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 1 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 2 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 5 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure Legends from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

36. Data from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 4 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 3 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

40. Data from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 3 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 3 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 6 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 2 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

Author

Flemington, Vikki, primary, Davies, Emma J., primary, Robinson, David, primary, Sandin, Linda C., primary, Delpuech, Oona, primary, Zhang, Pei, primary, Hanson, Lyndsey, primary, Farrington, Paul, primary, Bell, Sigourney, primary, Falenta, Katarzyna, primary, Gibbons, Francis D., primary, Lindsay, Nicola, primary, Smith, Aaron, primary, Wilson, Joanne, primary, Roberts, Karen, primary, Tonge, Michael, primary, Hopcroft, Philip, primary, Willis, Sophie E., primary, Roudier, Martine P., primary, Rooney, Claire, primary, Coker, Elizabeth A., primary, Jaaks, Patricia, primary, Garnett, Mathew J., primary, Fawell, Stephen E., primary, Jones, Clifford D., primary, Ward, Richard A., primary, Simpson, Iain, primary, Cosulich, Sabina C., primary, Pease, J. Elizabeth, primary, and Smith, Paul D., primary

Published
2023
Full Text
View/download PDF

46. Optimization of a Series of Novel, Potent and Selective Macrocyclic SYK Inhibitors

Author

Grimster, Neil Patrick, primary, Gingipalli, Lakshmaiah, additional, Balazs, Amber, additional, Barlaam, Bernard, additional, Boiko, Scott, additional, Boyd, Scott, additional, Dry, Hannah, additional, Goldberg, Frederick W., additional, Ikeda, Tim, additional, Johnson, Tony, additional, Kawatkar, Sameer, additional, Kemmitt, Paul, additional, Lamont, Scott, additional, Lorthioir, Olivier, additional, Mfuh, Adelphe, additional, Patel, Joe, additional, Pike, Andy, additional, Read, Jon, additional, Romero, Romulo, additional, Sarkar, Ujjal, additional, Sha, Li, additional, Simpson, Iain, additional, Song, Kun, additional, Su, Qibin, additional, Wang, Haixia, additional, Watson, David, additional, Wu, Allan, additional, Zehnder, Troy E., additional, Zheng, XiaoLan, additional, Li, Shaolu, additional, Dong, Zhiqiang, additional, Yang, Dejian, additional, Song, Yanwei, additional, Wang, Peng, additional, Liu, Xuemei, additional, Dowling, James E., additional, and Edmondson, Scott D., additional

Published
2023
Full Text
View/download PDF

47. Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors

Author

Harrison, David, primary, Bock, Mark G., additional, Doedens, John R., additional, Gabel, Christopher A., additional, Holloway, M. Katharine, additional, Lewis, Arwel, additional, Scanlon, Jane, additional, Sharpe, Andrew, additional, Simpson, Iain D., additional, Smolak, Pamela, additional, Wishart, Grant, additional, and Watt, Alan P., additional

Published
2022
Full Text
View/download PDF

48. 169 High-sensitivity troponin is a biomarker of medium term mortality in 20,000 consecutive hospital patients undergoing a blood test for any reason

Author

Hinton, Jonathan, primary, Mariathas, Mark, additional, Gabara, Lavinia, additional, Allan, Rick, additional, Nicholas, Zoe, additional, Kwok, Chun Shing, additional, Ramamoorthy, Sanjay, additional, Calver, Alison, additional, Corbett, Simon, additional, Rawlins, John, additional, Simpson, Iain, additional, Wilkinson, James, additional, Sirohi, Rohit, additional, Mahmoudi, Michael, additional, Martin, Glen, additional, Cook, Paul, additional, Mamas, Mamas, additional, and Curzen, Nick, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results